Sponsor Dossier
Ipsen
Sponsor Dossier for Ipsen. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BYLVAY
- Brand: CABOMETYX
- Brand: DIPHERELINE
- Brand: DYSPORT
- Brand: IQIRVO
- Brand: RELFYDESS
- Brand: SOHONOS
- Brand: SOMATULINE AUTOGEL
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
Ipsen is an Australian Private Company with ABN 47095036909, registered in Victoria. The entity is active and registered for GST.
Portfolio
Ipsen has 8 brands on the ARTG, of which 8 are indexable and 8 carry a Product Information document. 7 brands are PBS-listed, 7 have a PBAC outcome on record, and 6 have an AusPAR on record. Notable brands include BYLVAY, CABOMETYX, DIPHERELINE, DYSPORT, IQIRVO, RELFYDESS, SOHONOS, SOMATULINE AUTOGEL.
Therapeutic focus
— Oncology: 3 brands — Rare Disease: 2 brands — Hepatology: 1 brand — Dermatology: 1 brand — Neurology: 1 brand
PBS footprint
7 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 7 brands with a PBAC outcome on record. The latest AusPAR is 2025-08-19, across 6 brands with an AusPAR on record.